134 related articles for article (PubMed ID: 22694887)
1. Erlotinib-related bilateral anterior uveitis.
Ali K; Kumar I; Usman-Saeed M; Usman Saeed M
BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22694887
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of erlotinib related uveitis.
Kumar I; Ali K; Usman-Saeed M; Saeed MU
BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22892235
[TBL] [Abstract][Full Text] [Related]
3. Bilateral acute anterior uveitis: a rare ocular side effect of erlotinib.
Chan S; Ahern E; Chaudhry S; Hughes B
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31843782
[TBL] [Abstract][Full Text] [Related]
4. Bilateral anterior uveitis secondary to erlotinib.
Lim LT; Blum RA; Cheng CP; Hanifudin A
Eur J Clin Pharmacol; 2010 Dec; 66(12):1277-8. PubMed ID: 20680254
[No Abstract] [Full Text] [Related]
5. A case report of pseudo-exfoliation syndrome with prolonged corneal epithelial regeneration because of erlotinib-induced unilateral corneal ulcer and anterior uveitis.
Tamura M; Takai Y; Nakamura S; Ohira A
Acta Ophthalmol; 2020 Dec; 98(8):e1055-e1056. PubMed ID: 32483873
[No Abstract] [Full Text] [Related]
6. Erlotinib-associated bilateral anterior uveitis: resolution with posterior sub-Tenon's triamcinolone without erlotinib cessation.
Kirkpatrick CA; Almeida DR; Hornick AL; Chin EK; Boldt HC
Can J Ophthalmol; 2015 Oct; 50(5):e66-7. PubMed ID: 26455982
[No Abstract] [Full Text] [Related]
7. Erlotinib-associated acute pneumonitis: report of two cases.
Vahid B; Esmaili A
Can Respir J; 2007 Apr; 14(3):167-70. PubMed ID: 17464382
[TBL] [Abstract][Full Text] [Related]
8. Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer.
Makris D; Scherpereel A; Copin MC; Colin G; Brun L; Lafitte JJ; Marquette CH
BMC Cancer; 2007 Aug; 7():150. PubMed ID: 17683587
[TBL] [Abstract][Full Text] [Related]
9. Both gefitinib and erlotinib induced drug-related interstitial lung disease in a patient with pulmonary adenocarcinoma.
Wang KF; Chang CY; Chang SC; Liu YC; Yuan MK; Yang YH
J Chin Med Assoc; 2013 Mar; 76(3):173-5. PubMed ID: 23497972
[TBL] [Abstract][Full Text] [Related]
10. Case of erlotinib-induced photosensitivity.
Fukai T; Hasegawa T; Nagata A; Matsumura M; Kudo Y; Shiraishi E; Kamiya Y; Hirasawa Y; Ikeda S
J Dermatol; 2014 May; 41(5):445-6. PubMed ID: 24801921
[No Abstract] [Full Text] [Related]
11. Trichomegaly secondary to erlotinib.
Desai RU; Rachakonda LP; Saffra NA
Can J Ophthalmol; 2009 Dec; 44(6):e65. PubMed ID: 20052001
[No Abstract] [Full Text] [Related]
12. Drug-induced ocular inflammation.
Samalia P; Sims J; Niederer R
N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
[TBL] [Abstract][Full Text] [Related]
13. [Functional impairment and radiologic fasciitis under erlotinib therapy].
Osdoit S; Wierzbicka E; Guillet G
Ann Dermatol Venereol; 2011; 138(6-7):494-8. PubMed ID: 21700070
[TBL] [Abstract][Full Text] [Related]
14. Three cases of severe hepatic impairment caused by erlotinib.
Huang YS; An SJ; Chen ZH; Wu YL
Br J Clin Pharmacol; 2009 Sep; 68(3):464-7. PubMed ID: 19740406
[No Abstract] [Full Text] [Related]
15. Successful treatment of non-small cell lung cancer with gefitinib after severe erlotinib-related hepatotoxicity.
Kunimasa K; Yoshioka H; Iwasaku M; Nishiyama A; Korogi Y; Masuda G; Takaiwa T; Ishida T
Intern Med; 2012; 51(4):431-4. PubMed ID: 22333382
[TBL] [Abstract][Full Text] [Related]
16. Acute drug induced hepatitis due to erlotinib.
Ramanarayanan J; Scarpace SL
JOP; 2007 Jan; 8(1):39-43. PubMed ID: 17228132
[TBL] [Abstract][Full Text] [Related]
17. [Acneiforme rash in woman with pulmonary adenocarcinoma].
Navarro Martín M; Rodríguez Sánchez C; Delgado Fernández C; Mezquita Pérez L; Cruz Hernández JJ
Rev Clin Esp; 2008 May; 208(5):251-2. PubMed ID: 18457638
[No Abstract] [Full Text] [Related]
18. Successful erlotinib rechallenge after erlotinib-induced interstitial lung disease.
Dallas JL; Jantz MA; Lightsey JL; Sonntag C; Kaye FJ
J Thorac Oncol; 2011 Jun; 6(6):1142-3. PubMed ID: 21623280
[No Abstract] [Full Text] [Related]
19. Interstitial lung disease following erlotinib (Tarceva) in a patient who previously tolerated gefitinib (Iressa).
Tammaro KA; Baldwin PD; Lundberg AS
J Oncol Pharm Pract; 2005 Sep; 11(3):127-30. PubMed ID: 16390601
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of radiation fibrosis with erlotinib: another pattern of radiation recall phenomenon.
Arakawa H; Johkoh T; Sakai F; Kusumoto M; Hataji O; Taguchi O
Jpn J Radiol; 2011 Oct; 29(8):587-9. PubMed ID: 21928002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
